An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma

This study is currently recruiting participants.

Verified by Genentech, January 2007

First Received: November 24, 2004 Last Updated: January 22, 2007 History of Changes

Sponsor:	Genentech
Information provided by:	Genentech
ClinicalTrials.gov Identifier:	NCT00097565

Purpose

This is a prospective, observational, longitudinal, multicenter study of patients with newly diagnosed follicular Non Hodgkin's Lymphoma (NHL) designed to delineate differences in clinical outcome by comparing the effectiveness and safety of common treatment regimens.

Condition	Phase
Lymphoma, Non Hodgkin	Phase IV

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study
Official Title:	The National Lymphocare Study: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma

Resource links provided by NLM:

MedlinePlus related topics: Lymphoma

U.S. FDA Resources

Further study details as provided by Genentech:

Estimated Enrollment:	5000
Study Start Date:	September 2004
Estimated Study Completion Date:	September 2014

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Signed Informed Consent Form (unless the Institutional Review Board [IRB] has granted a waiver of consent)
Signed Authorization for the Use and Disclosure of Health Information document
Age ≥18 years
Histologic documentation of follicular NHL, according to Revised European-American Lymphoma (REAL) classification system, as assessed by the local pathologist and treating physician
Initial diagnosis of follicular B-cell NHL within 6 months prior to enrollment
Availability of cancer-specific historical data points in the patient's medical records

Exclusion Criteria:

Other indolent or histologic NHL subtypes
Diagnosis of lymphoma > 6 months prior to enrollment

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00097565

Contacts

Contact: Serika Kokubu

kokubu.serika@gene.com

Show 278 Study Locations

Sponsors and Collaborators

Genentech

Investigators

Study Director:

Jane Huang, M.D.

Genentech

More Information

No publications provided

Study ID Numbers:	U2963n
Study First Received:	November 24, 2004
Last Updated:	January 22, 2007
ClinicalTrials.gov Identifier:	NCT00097565 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Genentech:

Follicular Non-Hodgkin's Lymphoma

Additional relevant MeSH terms:

Lymphatic Diseases
Neoplasms
Immunoproliferative Disorders
Neoplasms by Histologic Type
Immune System Diseases

Lymphoma, Follicular
Lymphoproliferative Disorders
Lymphoma, Non-Hodgkin
Lymphoma

ClinicalTrials.gov processed this record on February 08, 2010